NCT02581553View on ClinicalTrials.gov

Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability

PHASE1CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

August 31, 2016

Conditions
Healthy
Interventions
DRUG

lesinurad/allopurinol 200/300 FDC tablets

DRUG

lesinurad 200 mg

DRUG

allopurinol 300 mg

DRUG

lesinurad/allopurinol 200/200 FDC tablets

DRUG

allopurinol 200 mg

Trial Locations (1)

78744

Austin

Sponsors
All Listed Sponsors
lead

Ardea Biosciences, Inc.

INDUSTRY